Dr. Stephen Robbins
March 2021Research at the Lady Davis Institute

A year with COVID-19: The therapeutic pipeline

Dr. Stephen Robbins, new Director of the Lady Davis Institute, and Dr. Donna Senger, of the LDI’s Cancer Axis, have received up to $6.7 million in federal support for a drug candidate that could bring relief to hospitalized patients with a severe case of COVID-19.

READ MORE →